What is Trevi Therapeutics, Inc.'s net investment in lease?

Trevi Therapeutics, Inc. (TRVI) reported net investment in lease of $610K in Q1 2026.

How has Trevi Therapeutics, Inc.'s net investment in lease changed year-over-year?

Trevi Therapeutics, Inc.'s net investment in lease decreased by 29.5% year-over-year, from $865K to $610K.

What is the long-term trend for Trevi Therapeutics, Inc.'s net investment in lease?

Over 5 years (2020 to 2025), Trevi Therapeutics, Inc.'s net investment in lease has grown at a 24.4% compound annual growth rate (CAGR), from $227K to $677K.

Trevi Therapeutics, Inc. TRVI Net Investment in Lease

Net Investment in Lease at other companies

Indivior Pharmaceuticals, Inc. INDV

——

LQD

Liquidia CorporationLQDA

——

Other financials

Income statement

See full

Operating income-$14.9M-30.0%

Net income-$13.2M-27.6%

EPS (diluted)-$0.090.0%

Balance sheet

See full

Cash & equivalents$19.4M+0.2%

Total debt$682.0K-28.7%

Total equity$172.1M+73.1%

Total assets$179.6M+67.8%

Cash flow

See full

Operating cash flow-$16.7M-23.8%

CapEx$102.0K—

Free cash flow-$16.8M—

Valuation

See full

Market cap$2.47B+152%

Enterprise value$2.45B+157%

Returns & leverage

See full

Return on equity-33.6%-9.4pp

Debt / equity0×0.0×

Current ratio24.8×+9.4×

Where this comes from

Reported directly by Trevi Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Trevi Therapeutics, Inc.'s net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Trevi Therapeutics, Inc.'s net investment in lease?: Trevi Therapeutics, Inc. (TRVI) reported net investment in lease of $610K in Q1 2026.
How has Trevi Therapeutics, Inc.'s net investment in lease changed year-over-year?: Trevi Therapeutics, Inc.'s net investment in lease decreased by 29.5% year-over-year, from $865K to $610K.
What is the long-term trend for Trevi Therapeutics, Inc.'s net investment in lease?: Over 5 years (2020 to 2025), Trevi Therapeutics, Inc.'s net investment in lease has grown at a 24.4% compound annual growth rate (CAGR), from $227K to $677K.